A clonal expression biomarker associates with lung cancer mortality
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A clonal expression biomarker associates with lung cancer mortality
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 25, Issue 10, Pages 1540-1548
Publisher
Springer Science and Business Media LLC
Online
2019-10-08
DOI
10.1038/s41591-019-0595-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer
- (2018) Won-Chul Lee et al. MODERN PATHOLOGY
- Phenotype molding of stromal cells in the lung tumor microenvironment
- (2018) Diether Lambrechts et al. NATURE MEDICINE
- SpatialDE: identification of spatially variable genes
- (2018) Valentine Svensson et al. NATURE METHODS
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
- (2017) Bernhard Mlecnik et al. JNCI-Journal of the National Cancer Institute
- Integrative clinical genomics of metastatic cancer
- (2017) Dan R. Robinson et al. NATURE
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival
- (2017) Bernhard Mlecnik et al. JNCI-Journal of the National Cancer Institute
- Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
- (2017) Bailiang Li et al. JAMA Oncology
- Gene expression markers of Tumor Infiltrating Leukocytes
- (2017) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer
- (2016) R. Gyanchandani et al. CLINICAL CANCER RESEARCH
- Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma
- (2016) Sudhanshu Shukla et al. JNCI-Journal of the National Cancer Institute
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
- (2016) Peter Goldstraw et al. Journal of Thoracic Oncology
- ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization
- (2016) Guangchuang Yu et al. Molecular BioSystems
- Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
- (2016) Joshua D Campbell et al. NATURE GENETICS
- Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma
- (2016) Sudhanshu Shukla et al. JNCI-Journal of the National Cancer Institute
- TCGA2STAT: simple TCGA data access for integrated statistical analysis in R
- (2015) Ying-Wooi Wan et al. BIOINFORMATICS
- Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity
- (2015) T.-M. Kim et al. CLINICAL CANCER RESEARCH
- The path to routine use of genomic biomarkers in the cancer clinic
- (2015) Paul C. Boutros GENOME RESEARCH
- Relapse models for clear cell renal carcinoma
- (2015) Sakshi Gulati et al. LANCET ONCOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- (2015) Lucy R Yates et al. NATURE MEDICINE
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients
- (2014) A. K. Reka et al. CARCINOGENESIS
- Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
- (2014) Sakshi Gulati et al. EUROPEAN UROLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients
- (2013) H. Tang et al. CLINICAL CANCER RESEARCH
- Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma
- (2013) I. I. Wistuba et al. CLINICAL CANCER RESEARCH
- Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients
- (2013) Sandy D. Der et al. Journal of Thoracic Oncology
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers
- (2013) S. Rousseaux et al. Science Translational Medicine
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
- (2012) Johannes R Kratz et al. LANCET
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Jetset: selecting the optimal microarray probe set to represent a gene
- (2011) Qiyuan Li et al. BMC BIOINFORMATICS
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas
- (2011) H. Okayama et al. CANCER RESEARCH
- Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
- (2011) David Venet et al. PLoS Computational Biology
- Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?
- (2010) J. Subramanian et al. JNCI-Journal of the National Cancer Institute
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Allele-specific copy number analysis of tumors
- (2010) P. Van Loo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
- (2009) Steffen Durinck et al. Nature Protocols
- Random survival forests
- (2008) Hemant Ishwaran et al. Annals of Applied Statistics
- A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma
- (2008) D. J. Raz et al. CLINICAL CANCER RESEARCH
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
- (2008) Gary M. Strauss et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started